Loading...

Abbott Laboratories (NYSE:ABT)

109.45 USD +3.24 USD ( +3.05% )
Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist

DCF Value

Estimated DCF Value of one ABT stock under the base case scenario is 71.5 USD. Compared to the current market price of 109.45 USD, the stock is Overvalued by 35%.

Estimated DCF Value of one NYSE:ABT stock is 71.5 USD. Compared to the current market price of 109.45 USD, the stock is Overvalued by 35% .

DCF valuation is one of two methods of placing a monetary value on a company; the other is Relative Valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

Discount Rate
7.85%
Terminal Growth
0%
Growth Period
5 Years
Discount Rate
7.85%
Terminal Growth
0%
Growth Period
5 Years

You can change any inputs, such as future revenue, using Present Value Calculation block.

ABT DCF Value
Base Case
71.5 USD
Overvaluation 35%
DCF Value
Price
Worst Case
Base Case
Best Case
Open DCF Settings
Close DCF Settings
Abbott Laboratories Competitors:
DCF Valuation
CNMD
Conmed Corp
7817
Paramount Bed Holdings Co Ltd
STE
STERIS plc
ELEAF
El En SpA
EDAP
Edap Tms SA
7733
Olympus Corp
HSKA
Heska Corp
VREX
Varex Imaging Corp

DCF Value Calculation

Capital Structure
From Present Value to DCF Value

Present Value 132B USD
+ Cash & Equivalents 9.8B USD
+ Investments 1.3B USD
Firm Value 143B USD
- Debt 17.3B USD
- Minority Interest 222M USD
Equity Value 125B USD
/ Shares Outstanding 1.8B
ABT DCF Value 71.5 USD
Overvalued by 35%

To view the process of calculating the Present Value of Abbott Laboratories' future free cash flow, see the Present Value Calculation block.

Present Value Calculation

Discounted Cash Flow Model
Present Value of Free Cash Flow

Rotate your device for better experience.

To view the process of deriving the DCF Value of one share from the estimated Present Value, see the DCF Value Calculation block.

DCF Model Financials
Financials used in the DCF Model

Sensitivity Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Analyze the possible values of ABT stock DCF Value given various model inputs such as Revenue Growth, Operating Margin, and Discount Rate.

See Also

Similar Stocks

ABT Stock DCF Valuation FAQ

What is the DCF value of one ABT stock?

Estimated DCF Value of one ABT stock under the base case scenario is 71.5 USD. Compared to the current market price of 109.45 USD, the stock is Overvalued by 35%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock intrinsic values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Using the DCF Operating Model we project Abbott Laboratories's future free cash flow and discount it at a selected discount rate to calculate its Present Value (132B USD).

2. DCF Value Calculation. We use the company's capital structure to calculate the total Equity Value based on the previously computed Present Value of the free cash flow. Dividing the Equity Value by the number of shares outstanding gives us the DCF Value of 71.5 USD per one ABT share.